Metabolite of ellagitannins, urolithin A induces autophagy and inhibits metastasis in human sw620 colorectal cancer cells

Mol Carcinog. 2018 Feb;57(2):193-200. doi: 10.1002/mc.22746. Epub 2017 Nov 26.

Abstract

Autophagy is an evolutionarily conserved pathway in which cytoplasmic contents are degraded and recycled. This study found that submicromolar concentrations of urolithin A, a major polyphenol metabolite, induced autophagy in SW620 colorectal cancer (CRC) cells. Exposure to urolithin A also dose-dependently decreased cell proliferation, delayed cell migration, and decreased matrix metalloproteinas-9 (MMP-9) activity. In addition, inhibition of autophagy by Atg5-siRNA, caspases by Z-VAD-FMK suppressed urolithin A-stimulated cell death and anti-metastatic effects. Micromolar urolithin A concentrations induced both autophagy and apoptosis. Urolithin A suppressed cell cycle progression and inhibited DNA synthesis. These results suggest that dietary consumption of urolithin A could induce autophagy and inhibit human CRC cell metastasis. Urolithins may thus contribute to CRC treatment and offer an alternative or adjunct chemotherapeutic agent to combat this disease.

Keywords: autophagy; colorectal cancer; matrix metallo proteinases; metastasis; urolithin A.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Autophagy / drug effects*
  • Caspases / metabolism
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / metabolism
  • Coumarins / pharmacology*
  • Humans
  • Hydrolyzable Tannins / pharmacology*
  • Matrix Metalloproteinase 9 / metabolism
  • RNA, Small Interfering / metabolism

Substances

  • Coumarins
  • Hydrolyzable Tannins
  • RNA, Small Interfering
  • 3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one
  • Caspases
  • Matrix Metalloproteinase 9